Skip to main content

Pharmacoresistance in Epilepsy

From Genes and Molecules to Promising Therapies

  • Book
  • © 2023

Overview

  • Contains the latest information on the development of pharmacoresistance in epilepsy

  • Discusses novel therapeutic strategies to counteract the development of pharmacoresistance

  • Presents new strategies to prevent or reduce the progression of the disease

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (26 chapters)

Keywords

About this book

This new edition of Pharmacoresistance in Epilepsy addresses all issues relating to drug-resistance in epilepsy, including studies in patients as well in experimental models and presents the basis for an understanding of recent developments in the pathogenesis and treatment of this condition. Important issues associated with drug-resistant epilepsy are reviewed and updated, such as abnormalities in inhibitory mechanisms, neurotoxicity and changes the immune system associated with this disorder, and the development of drug-resistance as consequence of chronic exposure to antiseizure-medications. Considering that a major obstacle is that epilepsy associated with drug-resistance cannot be controlled with the traditional antiseizure medications, specific chapters describe therapeutic strategies to prevent or reduce the progression of the disease with complementary medical therapies, such as transcranial focal stimulation to promote neuroprotection. Pharmacoresistance in Epilepsy is a valuable resource for anyone working in the field, whether studying epilepsy in the lab or treating it in an office.

Editors and Affiliations

  • Pharmacobiology Department, Center for Research and Advanced Studies, México, Mexico

    Luisa L. Rocha

  • Institute for Research in Physiopathology and Clinical Biochemistry (INFIBIOC), School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina

    Alberto Lazarowski

  • Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Federal University of São Paulo, Brazil

    Esper A. Cavalheiro

About the editors

Luisa Rocha is Professor in the Department of Pharmacobiology of the Center for Research and Advanced Studies in Mexico City, Mexico.

Esper Cavalheiro is Professor Emeritus at the Universidade Federal de Sao Paulo/Escola Paulista de Medicina, Brasil.

Alberto Lazarowski is Full Professor at Universidad de Buenos Aires, Argentina.

Bibliographic Information

  • Book Title: Pharmacoresistance in Epilepsy

  • Book Subtitle: From Genes and Molecules to Promising Therapies

  • Editors: Luisa L. Rocha, Alberto Lazarowski, Esper A. Cavalheiro

  • DOI: https://doi.org/10.1007/978-3-031-36526-3

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023

  • Hardcover ISBN: 978-3-031-36525-6Published: 30 August 2023

  • Softcover ISBN: 978-3-031-36528-7Due: 13 September 2024

  • eBook ISBN: 978-3-031-36526-3Published: 29 August 2023

  • Edition Number: 2

  • Number of Pages: XV, 596

  • Number of Illustrations: 5 b/w illustrations, 79 illustrations in colour

  • Topics: Neurosciences, Neurology, Pharmacology/Toxicology

Publish with us